内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Kodiak Sciences Inc.

KOD · Nasdaq · CIK 0001468748 · Healthcare · Biotechnology

内部人信号

69.0 / 100

1 位买方 · 82 条买入交易行 · $157.0M 买入总额

为什么有这个信号？

买方广度较低
买入规模较强
角色较强
近期性中等
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+24.8 / 25
角色+20.0 / 20
近期性+7.3 / 10
确信度+9.9 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ✓ 角色得分高 · 买入者中职位最高的是：Director,TenPercentOwner
  • ✓ Recent activity · latest purchase 2026-09-29

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPDirector,TenPercentOwner
●●●●
BORGESON JOHN A.Chief Financial Officer
○▼
PERLROTH VICTORChairman and CEO
○
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方1
买入集中度100%最大买方： 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · $157.0M
聚集买入 · 15天1 insider峰值活动： 2026-09-28–2026-09-29

Roles in the peak window: Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

69.0 / 100

最新留档分数

↓ -0.2 pts相对上一个留档快照
  1. 69.6
  2. 69.4
  3. 69.3
  4. 69.2
  5. 69.0

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

84买入
6卖出
8其他 Form 4 交易行
10SEC 申报 · 365天
买入82 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他4 exercise / withholding / award / gift / other lines
10b5-1／计划交易Unavailable

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
+203.8%
3M
+143.0%
6M
+131.7%
12M
+590.7%

波动率与流动性

波动率
172.0%
Beta
—
平均每日成交额
USD 160.0M

估值

市值
USD 6.3B
P/E
—

基本面

利润率
—
ROE
-146.1%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-06 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
9,376,012
上期报告
10,672,646
日均成交量
5,205,761
回补天数
1.8

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-09-29667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock33,726USD 85.04USD 2,868,175SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock681,866USD 88.77USD 60,530,796SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock418,323USD 83.58USD 34,962,746SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock807,840USD 72.57USD 58,627,586SEC 申报 ↗
2025-12-18667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock2,608,696USD 23.00USD 60,000,008SEC 申报 ↗
2022-06-06667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock303,917USD 7.77USD 2,361,076SEC 申报 ↗
2022-06-03667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock102,200USD 7.95USD 812,196SEC 申报 ↗
2022-06-02667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock166,232USD 7.67USD 1,274,650SEC 申报 ↗
2022-05-27667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock155,940USD 6.87USD 1,070,998SEC 申报 ↗
2022-05-26667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock93,322USD 6.74USD 628,634SEC 申报 ↗
2022-05-25667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock101,144USD 6.56USD 663,777SEC 申报 ↗
2022-05-18667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock223,766USD 5.97USD 1,335,678SEC 申报 ↗
2022-05-17667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock110,824USD 5.99USD 663,836SEC 申报 ↗
2022-05-16667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock122,100USD 5.72USD 697,871SEC 申报 ↗
2022-02-17667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock300,000USD 54.56USD 16,366,800SEC 申报 ↗

Form 4 申报证据

98 transaction lines in the latest 365-day window; 518 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-29667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock33,726USD 85.04USD 2,868,175SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock681,866USD 88.77USD 60,530,796SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock418,323USD 83.58USD 34,962,746SEC 申报 ↗
展开近期 Form 4 证据 (13 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-29667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock33,726USD 85.04USD 2,868,175SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock681,866USD 88.77USD 60,530,796SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock418,323USD 83.58USD 34,962,746SEC 申报 ↗
2026-09-28667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock807,840USD 72.57USD 58,627,586SEC 申报 ↗
2026-09-25PERLROTH VICTOR期权行权／转换 (M)Common Stock1,280,524USD 4.20USD 5,381,943SEC 申报 ↗
2026-06-04BORGESON JOHN A.卖出 (S)Common Stock30,000USD 34.10USD 1,023,009SEC 申报 ↗
2026-06-04BORGESON JOHN A.期权行权／转换 (M)Common Stock30,000USD 1.04USD 31,200SEC 申报 ↗
2026-04-15BORGESON JOHN A.期权行权／转换 (M)Common Stock28,614USD 1.04USD 29,759SEC 申报 ↗
2026-04-02BORGESON JOHN A.卖出 (S)Common Stock30,000USD 39.92USD 1,197,488SEC 申报 ↗
2026-04-02BORGESON JOHN A.期权行权／转换 (M)Common Stock30,000USD 1.04USD 31,200SEC 申报 ↗
2026-03-25PERLROTH VICTOR期权行权／转换 (M)Common Stock300,000USD 1.04USD 312,000SEC 申报 ↗
2025-12-26PERLROTH VICTOR赠与 (G)Common Stock12,500USD 0.00USD 0SEC 申报 ↗
2025-12-18667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock2,608,696USD 23.00USD 60,000,008SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码KOD
CIK0001468748
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
交易所Nasdaq

数据覆盖

本地 Form 4 历史518 transaction lines from 2020-02-24 to 2026-09-29
305 P purchase lines · 152 S sale lines · 61 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.